 |
 |

COMMENTS AND OPINIONS
Are We Ignoring the Elephant in the Room?
Ayad Jindeel, MD
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
Cook et al1 reported no association between migraine and coronary heart disease (CHD) after a mean of 12 years of follow-up in the Physicians' Health Study (PHS). This study included information through March 2000. Kurth et al2 extended the follow-up period of the PHS participants to February 2005. They concluded that "migraine was associated with increased risk of major CVD [cardiovascular disease]"2(p795) and that "[t]he associations between migraine and major CVD, ischemic stroke, and MI [myocardial infarction] were not significantly modified by smoking and hypertension status or by randomized aspirin assignment."2(p797) The authors "had no information about the use of migraine-specific drugs (ie, triptans and ergot alkaloids)."2(p800) However, in a study by the same authors regarding the Women Health Study "women were asked on the 48-month questionnaire to provide information regarding medication use during the previous 2 weeks. The frequency of migraine-specific drug use among women who . . . [Full Text of this Article] AUTHOR INFORMATION
RELATED ARTICLE
Migraine and Risk of Cardiovascular Disease in Men
Tobias Kurth, J. Michael Gaziano, Nancy R. Cook, Vadim Bubes, Giancarlo Logroscino, Hans-Christoph Diener, and Julie E. Buring
Arch Intern Med. 2007;167(8):795-801.
ABSTRACT
| FULL TEXT
|